Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

374.26
Delayed Data
As of Aug 17
 +2.48 / +0.67%
Today’s Change
281.89
Today|||52-Week Range
505.49
-0.45%
Year-to-Date

Today’s Trading

Previous close371.78
Today’s open373.00
Day’s range370.17 - 377.86
Volume669,593
Average volume (3 months)858,075
Market cap$38.4B
Data as of 4:00pm ET, 08/17/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)+24.42%
Earnings growth (next 5 years)+9.96%
Revenue growth (last year)+20.82%
P/E ratio27.1
Price/Sales7.42
Price/Book6.34

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.08-0.63%
VRTXVertex Pharmaceutica...+1.12+0.64%
BAXBaxter International...+0.46+0.64%
ALXNAlexion Pharmaceutic...-1.28-1.09%
Data as of 4:00pm ET, 08/17/2018

Financials

Next reporting dateNovember 6, 2018
EPS forecast (this quarter)$5.13
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts